These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

767 related articles for article (PubMed ID: 30036646)

  • 1. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.
    Bajaj JS; Vargas HE; Reddy KR; Lai JC; O'Leary JG; Tandon P; Wong F; Mitrani R; White MB; Kelly M; Fagan A; Patil R; Sait S; Sikaroodi M; Thacker LR; Gillevet PM
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):756-765.e3. PubMed ID: 30036646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality.
    Chen Y; Guo J; Qian G; Fang D; Shi D; Guo L; Li L
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1429-37. PubMed ID: 25711972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis.
    Bajaj JS; Reddy KR; O'Leary JG; Vargas HE; Lai JC; Kamath PS; Tandon P; Wong F; Subramanian RM; Thuluvath P; Fagan A; White MB; Gavis EA; Sehrawat T; de la Rosa Rodriguez R; Thacker LR; Sikaroodi M; Garcia-Tsao G; Gillevet PM
    Gastroenterology; 2020 Nov; 159(5):1715-1730.e12. PubMed ID: 32687928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.
    Maslennikov R; Ivashkin V; Efremova I; Poluektova E; Kudryavtseva A; Krasnov G
    World J Gastroenterol; 2022 Mar; 28(10):1067-1077. PubMed ID: 35431497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis.
    Piano S; Tonon M; Vettore E; Stanco M; Pilutti C; Romano A; Mareso S; Gambino C; Brocca A; Sticca A; Fasolato S; Angeli P
    J Hepatol; 2017 Dec; 67(6):1177-1184. PubMed ID: 28733221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis.
    O'Leary JG; Reddy KR; Garcia-Tsao G; Biggins SW; Wong F; Fallon MB; Subramanian RM; Kamath PS; Thuluvath P; Vargas HE; Maliakkal B; Tandon P; Lai J; Thacker LR; Bajaj JS
    Hepatology; 2018 Jun; 67(6):2367-2374. PubMed ID: 29315693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.
    Solé C; Guilly S; Da Silva K; Llopis M; Le-Chatelier E; Huelin P; Carol M; Moreira R; Fabrellas N; De Prada G; Napoleone L; Graupera I; Pose E; Juanola A; Borruel N; Berland M; Toapanta D; Casellas F; Guarner F; Doré J; Solà E; Ehrlich SD; Ginès P
    Gastroenterology; 2021 Jan; 160(1):206-218.e13. PubMed ID: 32941879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal microbiome disruption in patients in a long-term acute care hospital: A case for development of microbiome disruption indices to improve infection prevention.
    Halpin AL; de Man TJ; Kraft CS; Perry KA; Chan AW; Lieu S; Mikell J; Limbago BM; McDonald LC
    Am J Infect Control; 2016 Jul; 44(7):830-6. PubMed ID: 26905790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA.
    Hernaez R; Kramer JR; Liu Y; Tansel A; Natarajan Y; Hussain KB; Ginès P; Solà E; Moreau R; Gerbes A; El-Serag HB; Kanwal F
    J Hepatol; 2019 Apr; 70(4):639-647. PubMed ID: 30590100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microbiota in cirrhosis and its role in hepatic decompensation.
    Trebicka J; Macnaughtan J; Schnabl B; Shawcross DL; Bajaj JS
    J Hepatol; 2021 Jul; 75 Suppl 1(Suppl 1):S67-S81. PubMed ID: 34039493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death.
    Xu R; Tan C; Zhu J; Zeng X; Gao X; Wu Q; Chen Q; Wang H; Zhou H; He Y; Pan S; Yin J
    Crit Care; 2019 May; 23(1):195. PubMed ID: 31151471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year transplant-free survival following hospital discharge after ICU admission for ACLF in the Netherlands.
    de Haan J; Termorshuizen F; de Keizer N; Gommers D; Hoed CD
    J Hepatol; 2024 Aug; 81(2):238-247. PubMed ID: 38479613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.
    Chen T; Yang Z; Choudhury AK; Al Mahtab M; Li J; Chen Y; Tan SS; Han T; Hu J; Hamid SS; Huei LG; Ghazinian H; Nan Y; Chawla YK; Yuen MF; Devarbhavi H; Shukla A; Abbas Z; Sahu M; Dokmeci AK; Lesmana LA; Lesmana CRA; Xin S; Duan Z; Guo W; Ma K; Zhang Z; Cheng Q; Jia J; Sharma BC; Sarin SK; Ning Q
    Hepatol Int; 2019 Nov; 13(6):695-705. PubMed ID: 31650510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered profile of human gut microbiome is associated with cirrhosis and its complications.
    Bajaj JS; Heuman DM; Hylemon PB; Sanyal AJ; White MB; Monteith P; Noble NA; Unser AB; Daita K; Fisher AR; Sikaroodi M; Gillevet PM
    J Hepatol; 2014 May; 60(5):940-7. PubMed ID: 24374295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.
    Sargenti K; Prytz H; Nilsson E; Kalaitzakis E
    Scand J Gastroenterol; 2015 Jul; 50(7):875-83. PubMed ID: 25697824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V;
    J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum sodium, model for end-stage liver disease, and a recent invasive procedure are risk factors for severe acute-on-chronic liver failure and death in cirrhotic patients hospitalized with bacterial infection.
    Lopes-Secundo TM; Sevá-Pereira T; Correa BR; Silva NCM; Imbrizi MR; Cunha-Silva M; Soares EC; Almeida JRS
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1055-1059. PubMed ID: 29944488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes After Listing for Liver Transplant in Patients With Acute-on-Chronic Liver Failure: The Multicenter North American Consortium for the Study of End-Stage Liver Disease Experience.
    O'Leary JG; Bajaj JS; Tandon P; Biggins SW; Wong F; Kamath PS; Garcia-Tsao G; Maliakkal B; Lai J; Fallon M; Vargas HE; Thuluvath P; Subramanian R; Thacker LR; Reddy KR
    Liver Transpl; 2019 Apr; 25(4):571-579. PubMed ID: 30724010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
    Kerbert AJC; Verspaget HW; Navarro ÀA; Jalan R; Solà E; Benten D; Durand F; Ginès P; van der Reijden JJ; van Hoek B; Coenraad MJ;
    Crit Care; 2017 Dec; 21(1):321. PubMed ID: 29268760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron deficiency anemia-related gut microbiota dysbiosis in infants and young children: A pilot study.
    Muleviciene A; D'Amico F; Turroni S; Candela M; Jankauskiene A
    Acta Microbiol Immunol Hung; 2018 Dec; 65(4):551-564. PubMed ID: 30418043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.